The Community Guide

- gsearch

Search Results

Narrow Results:

2020 1
2016 1
2015 1

Journal Article 3

1 - 3 of 3 Results

Refine Results

Refine Results:

Multidrug Resistant Tuberculosis in Patients with HIV: Management Considerations within High-Resourced Settings

CITE Title : Multidrug Resistant Tuberculosis in Patients with HIV: Management Considerations within High-Resourced Settings Personal Author(s) : Wilson, John W.;Nilsen, Diana M.;Marks, Suzanne M.; Published Date : 1 2020;1-2020; Source : Ann Am Thorac Soc. 17(1):16-23 URL : https://stacks.cdc.gov/view/cdc/83987 Wilson, John W. et al. (2020). Multidrug Resistant Tuberculosis in Patients with HIV: Management Considerations within High-Resourced Settings. 17(1). Wilson, John W. and Nilsen, Diana M. and Marks, Suzanne M. "Multidrug Resistant Tuberculosis in Patients with HIV: Management Considerations within High-Resourced Settings" 17, no. 1 (2020) Wilson, John W. et al. "Multidrug Resistant Tuberculosis in Patients with HIV: Management Considerations within High-Resourced Settings" vol. 17, no. 1, 2020 Export RIS Citation Information.

:

Wilson, John W. ;

Nilsen, Diana M.

1 2020 | Ann Am Thorac Soc. 17(1):16-23

:

The management of multidrug-resistant tuberculosis (MDR TB) is notably complex among patients with human immunodeficiency virus (HIV). TB treatment re...
A farewell to didanosine: harm reduction and cost savings by eliminating use of didanosine

CITE Title : A farewell to didanosine: harm reduction and cost savings by eliminating use of didanosine Personal Author(s) : Dziuban, Eric J;Raizes, Elliot;Koumans, Emilia H; Published Date : 10 2015;10-2015; Source : Int J STD AIDS. 26(12):903-906 URL : https://stacks.cdc.gov/view/cdc/36819 Dziuban, Eric J et al. (2015). A farewell to didanosine: harm reduction and cost savings by eliminating use of didanosine. 26(12). Dziuban, Eric J and Raizes, Elliot and Koumans, Emilia H "A farewell to didanosine: harm reduction and cost savings by eliminating use of didanosine" 26, no. 12 (2015) Dziuban, Eric J et al. "A farewell to didanosine: harm reduction and cost savings by eliminating use of didanosine" vol. 26, no. 12, 2015 Export RIS Citation Information.

:

Dziuban, Eric J ;

Raizes, Elliot

10 2015 | Int J STD AIDS. 26(12):903-906

:

Didanosine (ddI) is a nucleoside reverse transcriptase inhibitor associated with adverse events and public health concerns which have diminished its p...
Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness☆

CITE Title : Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness☆ Personal Author(s) : Whiteman, Maura K.;Jeng, Gary;Samarina, Anna;Akatova, Natalia;Martirosyan, Margarita;Kissin, Dmitry M.;Curtis, Kathryn M.;Marchbanks, Polly A.;Hillis, Susan D.;Mandel, Michele G.;Jamieson, Denise J.; Published Date : 1 2016;1-2016; Source : Contraception. 93(1):17-24 URL : https://stacks.cdc.gov/view/cdc/37018 Whiteman, Maura K. et al. (2016). Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness☆. 93(1). Whiteman, Maura K. et al. "Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness☆" 93, no. 1 (2016) Whiteman, Maura K. et al. "Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness☆" vol. 93, no. 1, 2016 Export RIS Citation Information.

:

Whiteman, Maura K. ;

Jeng, Gary

1 2016 | Contraception. 93(1):17-24

:

ObjectiveTo examine the associations between hormonal contraceptive use and measures of HIV disease progression and antiretroviral treatment (ART) eff...